Joseph L. Herring, CEO of Covance Drug Division at LABORATORY CORP OF AMERICA HOLDINGS (LH), sold 36,876 shares at $121.56 ($4.5M) on 2015-02-25, disclosed to the SEC on 2015-02-27.
Open-market sale of $4.5M LH by CEO of Covance Drug Division. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.56 | 30,718 | $3.7M | 83.2% |
| 2 | $122.03 | 6,158 | $751K | 16.8% |
| Total | $121.64 avg | 36,876 | $4.5M | 100% |
| Filing → |
| CVD | SELL | 2014-12-19 | $3.4M | — | Filing → |
| CVD | SELL | 2014-02-11 | $11.7M | — | Filing → |
| CVD | SELL | 2013-11-06 | $8.2M | — | Filing → |